DK0595924T3 - Antagonister for blodpladeaktiverende faktorer - Google Patents
Antagonister for blodpladeaktiverende faktorerInfo
- Publication number
- DK0595924T3 DK0595924T3 DK92915895T DK92915895T DK0595924T3 DK 0595924 T3 DK0595924 T3 DK 0595924T3 DK 92915895 T DK92915895 T DK 92915895T DK 92915895 T DK92915895 T DK 92915895T DK 0595924 T3 DK0595924 T3 DK 0595924T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- pyrrolo
- pyridin
- carbonyl
- paf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73168191A | 1991-07-17 | 1991-07-17 | |
| PCT/US1992/005890 WO1993001813A1 (en) | 1991-07-17 | 1992-07-14 | Platelet activating factor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0595924T3 true DK0595924T3 (da) | 1999-11-01 |
Family
ID=24940541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92915895T DK0595924T3 (da) | 1991-07-17 | 1992-07-14 | Antagonister for blodpladeaktiverende faktorer |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5459152A (da) |
| EP (1) | EP0595924B1 (da) |
| JP (1) | JP3135917B2 (da) |
| KR (1) | KR100251603B1 (da) |
| AT (1) | ATE178796T1 (da) |
| AU (1) | AU651243B2 (da) |
| CA (1) | CA2112562A1 (da) |
| DE (1) | DE69228932T2 (da) |
| DK (1) | DK0595924T3 (da) |
| ES (1) | ES2131530T3 (da) |
| GR (1) | GR3030208T3 (da) |
| IE (1) | IE922293A1 (da) |
| IL (1) | IL102494A0 (da) |
| PT (1) | PT100698B (da) |
| WO (1) | WO1993001813A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486525A (en) * | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
| US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
| US6630496B1 (en) | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| AU6762400A (en) * | 1999-08-12 | 2001-03-13 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
| DE10004157A1 (de) * | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
| WO2011100359A1 (en) * | 2010-02-09 | 2011-08-18 | Ironwood Pharmaceuticals, Inc. | Cannabinoid agonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2541280B1 (fr) * | 1983-01-13 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent |
| FR2617484B1 (fr) * | 1987-07-02 | 1989-10-20 | Rhone Poulenc Sante | Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre |
| FR2626004B1 (fr) * | 1988-01-20 | 1991-08-02 | Rhone Poulenc Sante | Procede de preparation du (pyridyl-3)-3 1h, 3h-pyrrolo (1,2-c) thiazolecarbonitrile-7 |
| JP3061631B2 (ja) * | 1989-10-11 | 2000-07-10 | 山之内製薬株式会社 | 新規なヘテロ環化合物およびその製造法 |
-
1992
- 1992-07-14 CA CA002112562A patent/CA2112562A1/en not_active Abandoned
- 1992-07-14 IL IL102494A patent/IL102494A0/xx unknown
- 1992-07-14 KR KR1019940700139A patent/KR100251603B1/ko not_active Expired - Fee Related
- 1992-07-14 WO PCT/US1992/005890 patent/WO1993001813A1/en not_active Ceased
- 1992-07-14 IE IE229392A patent/IE922293A1/en unknown
- 1992-07-14 EP EP92915895A patent/EP0595924B1/en not_active Expired - Lifetime
- 1992-07-14 AU AU23391/92A patent/AU651243B2/en not_active Ceased
- 1992-07-14 US US08/162,034 patent/US5459152A/en not_active Expired - Fee Related
- 1992-07-14 ES ES92915895T patent/ES2131530T3/es not_active Expired - Lifetime
- 1992-07-14 JP JP05502913A patent/JP3135917B2/ja not_active Expired - Fee Related
- 1992-07-14 DE DE69228932T patent/DE69228932T2/de not_active Expired - Fee Related
- 1992-07-14 DK DK92915895T patent/DK0595924T3/da active
- 1992-07-14 AT AT92915895T patent/ATE178796T1/de not_active IP Right Cessation
- 1992-07-16 PT PT100698A patent/PT100698B/pt not_active IP Right Cessation
-
1999
- 1999-05-13 GR GR990401293T patent/GR3030208T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE178796T1 (de) | 1999-04-15 |
| AU651243B2 (en) | 1994-07-14 |
| EP0595924B1 (en) | 1999-04-14 |
| ES2131530T3 (es) | 1999-08-01 |
| PT100698A (pt) | 1993-10-29 |
| JP3135917B2 (ja) | 2001-02-19 |
| CA2112562A1 (en) | 1993-02-04 |
| DE69228932T2 (de) | 1999-11-11 |
| GR3030208T3 (en) | 1999-08-31 |
| AU2339192A (en) | 1993-02-23 |
| EP0595924A1 (en) | 1994-05-11 |
| US5459152A (en) | 1995-10-17 |
| PT100698B (pt) | 1999-07-30 |
| IL102494A0 (en) | 1993-01-14 |
| DE69228932D1 (de) | 1999-05-20 |
| JPH06510027A (ja) | 1994-11-10 |
| EP0595924A4 (en) | 1994-08-24 |
| KR100251603B1 (ko) | 2000-05-01 |
| WO1993001813A1 (en) | 1993-02-04 |
| IE922293A1 (en) | 1993-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL111963A0 (en) | Platelet activating factor antagonists: imidazopyridine indoles | |
| AU5429596A (en) | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists | |
| IL93508A0 (en) | Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers | |
| FI20115753L (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
| DK0595924T3 (da) | Antagonister for blodpladeaktiverende faktorer | |
| ATE214929T1 (de) | Verwendung von 7-(2-oxa-5,8-diazabicyclo 4.3.0)non-8-yl)-chinoloncarbonsäure- und - naphthyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| NO172575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater | |
| DE69923467D1 (de) | 2,3-disubstituierte pyridinderivate, verfahren zur derren herstellung, sie enthaltende wirkstoffzubereitungen und zwischenprodukte für die herstellung | |
| NO902710D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater. | |
| MY105555A (en) | Heterocyclicguanidines as 5ht 3 antagonists. | |
| DE69514532D1 (de) | Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung | |
| DE59106334D1 (de) | Giessmasse zur Herstellung keramischer Grünfolien und ihre Verwendung. | |
| HUT55003A (en) | Process for producing acyl derivatives of hydroxy-pyrimidines | |
| FI910816L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi | |
| DE69429447D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen | |
| EP0122155A3 (en) | Improvements in or relating to naphthylglycyl cephalosporin derivatives | |
| FI913656A7 (fi) | Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi | |
| ITMI941939A0 (it) | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids | |
| FI954169A0 (fi) | Menetelmä 3-substituoitujen 2-oksoindolijohdannaisten valmistamiseksi | |
| ATE216995T1 (de) | Kristalline mupirocinpolymorphe | |
| ES2009363A6 (es) | Procedimiento de preparacion de nuevos derivados de octahidro-indenofurano. | |
| PL288352A1 (en) | Method of obtaining bisindole alkaloids exhibiting cytostatic effect | |
| IT1244725B (it) | 1-b-ribofuranosil-pirazol-derivati e relativo processo di produzione e impiego farmacologico | |
| IT8321417A0 (it) | Procedimento per preparare derivati dell'1-(fenil)-1-idrossi-2-ammino-3-fluoro-propano e loro intermedi. | |
| NO171451C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater |